Johnathon Halvorson named CMO of Kenvue
Article excerpt
Highlighted: the sentence this signal was extracted from
Johnathon Halvorson named CMO of Kenvue. Tylenol parent Kenvue has named Johnathon (Jon) Halvorson its chief digital & marketing officer. In his new role, he will be responsible for "driving marketing excellence and transforming the company's digital commerce strategy," according to the company. Halvorson joins the company at a crucial time. Tylenol, one of the company's signature products, was accused of being a possible causal contributor to Autism Spectrum Disorder. Though several studies point to other factors (including genetics), the controversy has nonetheless inspired lawsuits against the brand. Earlier this month, Kimberly-Clark agreed to purchase Kenvue, which also markets Band-Aid, Listerine, Zyrtec and Benadryl, for more than $48 billion. Pending shareholder approval, that deal is expected to close in the second quarter of 2026, with Kimberly-Clark shareholders controlling 56% of the combined company and Kenvue shareholders holding 46%. Halvorson joins Kenvue from Mondelez International where he was most recently senior vice president of consumer experience and digital commerce and led teams in digital marketing, AI-adoption and consumer engagement for brands including Cadbury, Oreo, Ritz and Chips Ahoy. Halvorson has also held positions at X (when it was still Twitter) as director of global video strategy and at General Motors as director of global media...
Keep reading with a free account
The rest of this article, and every signal for Kenvue, is in your free account.
